Q/C Technologies, Inc.
Price
Key statistics
- Forward rate
- $0.00
- Yield
- 0.00%
- Payout ratio
- 0.00%
- Frequency
- Unknown
Q/C Technologies, Inc. is a clinical-stage biopharmaceutical and computing technology company focused on developing therapeutic platforms and advanced energy-efficient computing solutions. Q/C Technologies operates through Pharmaceuticals and Computing Technology segments. In pharmaceuticals, the company develops Isomyosamine, a small molecule designed to regulate the immunometabolic system in conditions such as autoimmune disease, sarcopenia, frailty, rheumatoid arthritis, and inflammatory bowel disease, and Supera-CBD, a synthetic cannabidiol analog under development for epilepsy, pain, and anxiety or depression. In computing, Q/C Technologies is engaged in photonic and quantum-class computing concepts, including laser-based processing systems intended for high-performance applications in areas such as blockchain and cryptocurrency infrastructure. Headquartered in New York, Q/C Technologies positions itself at the intersection of biotechnology and next-generation computing, serving markets that span healthcare innovation and specialized digital infrastructure.
- Sector
- Technology
- Industry
- Computer Hardware
- Employees
- 3
- Headquarters
- New York, NY, United States
- Website
- www.qctechnologies.com